Core Insights - The company has transitioned from an internet medical beauty platform to a light medical beauty chain, facing skepticism and criticism from the market regarding its strategy [1] - The opening of the 51st store marks a significant turning point for the company, emphasizing a focus on scale despite the associated financial pressures and temporary losses [2] - The company aims to establish a thousand-store chain, prioritizing infrastructure development to enhance long-term competitiveness through improved supply chain and cost structure [2] Group 1 - The company has opened 51 stores, indicating a pivotal moment in its growth strategy [2] - The focus on scale allows for cost dilution in marketing and fixed costs, while enhancing supply chain stability and purchasing power [2] - Approximately 50% of new customers are acquired through referrals from existing users, significantly reducing marketing expenses [2] Group 2 - The company has surpassed 110,000 treatments, which, along with the store count, serves as critical indicators of progress [3] - By 2026, the company aims to maintain expansion while improving gross margins and achieving overall profitability in a single quarter [3] - The market is shifting from a seller's market to a buyer's market, with larger, standardized institutions gaining more negotiating power and the ability to lower consumer costs [3] Group 3 - The company plans to diversify its product offerings and expand its medical team while continuing to densify its store network [3] - Exploration of more IP collaborations is on the agenda, with profitability expected to follow once the infrastructure is fully established [3]

Core Insights - The company has transitioned from an internet medical beauty platform to a light medical beauty chain, opening its 51st store, marking a significant turning point despite external skepticism [2] - The focus over the past two years has been on scaling, with a strategy aimed at establishing a thousand-store chain, which has led to short-term losses due to heavy asset investment [2] - The medical beauty industry’s cost structure allows for marketing and fixed costs to be diluted through scale, while long-term competitiveness is determined by supply chain efficiency [2] Group 1 - The company has achieved a significant milestone with over 110,000 treatments performed, indicating a positive turning point alongside the opening of 51 stores [3] - Approximately 50% of new customers are acquired through referrals from existing users, significantly reducing marketing costs [3] - The operational data comparison between first-tier and non-first-tier cities shows minimal differences in customer metrics, suggesting that success depends more on standardization and cross-regional management than on geographic location [3] Group 2 - The company aims to enhance gross margins and achieve overall profitability on a quarterly basis by 2026, shifting focus from mere expansion to efficiency optimization and structural improvement [3][4] - Plans for 2026 include expanding product offerings, increasing the medical team size, and densifying the store network, alongside exploring more IP collaborations [4] - The industry is evolving from a seller's market to a buyer's market, with larger and standardized institutions gaining more bargaining power and the ability to lower consumer costs [3]

Core Viewpoint - The era of upstream medical beauty supply chain manufacturers relying solely on price control to maintain high profits may be coming to an end, indicating a significant shift in the industry's development logic [2][4]. Group 1: Industry Dynamics - New Oxygen has reached cooperation agreements with 14 upstream manufacturers, including major players like Allergan and Huaxi Biological, marking a pause in the pricing power battle that dominated the previous year [3]. - The medical beauty industry is experiencing a restructuring of power dynamics between upstream and downstream players, suggesting a transformation in the overall industry landscape [4]. Group 2: Pricing Strategies - New Oxygen's founder, Jin Xing, aims to lower the prices of medical beauty projects, citing high operational costs and supplier pricing as key factors for the inflated prices in China compared to countries like South Korea [6]. - The introduction of the "Miracle Tongyan 1.0" project by New Oxygen, priced at 4,999 yuan per unit, significantly undercuts the traditional market price of over 10,000 yuan, leading to backlash from suppliers [6][7]. - The pricing strategy continued to evolve with the launch of "Miracle Tongyan 3.0," which further reduced the price to 2,999 yuan, setting a new low in the industry [7]. Group 3: Supplier Relationships - Despite previous conflicts, some suppliers have reconciled with New Oxygen, indicating a shift in relationships as the market dynamics change [9]. - New Oxygen's purchasing power has increased, allowing it to negotiate better prices with suppliers, as it has established a significant presence with 50 stores across 16 cities by the end of 2025 [11]. Group 4: Market Supply and Demand - The balance of pricing power is shifting towards buyers, with an increase in the number of suppliers and products available, leading to a more competitive market environment [11][14]. - The regulatory environment is improving, with a significant increase in the number of medical beauty device registrations, which is expected to further enhance supply [13]. Group 5: Future Outlook - The medical beauty industry is transitioning from a phase of rapid, unregulated growth to a more structured and value-focused era, emphasizing the importance of quality over price competition [14][16]. - New Oxygen faces challenges in maintaining its scale while achieving profitability and balancing relationships with suppliers, which will be crucial for its successful transformation [15].

Core Viewpoint - The Chinese medical beauty industry is transitioning from chaotic growth to a more regulated, rational, and value-focused era [1][11] Group 1: Industry Dynamics - The era of upstream medical beauty suppliers relying solely on price control to maintain high profits is likely over, as evidenced by recent collaborations between New Oxygen and 14 upstream manufacturers [2] - The pricing power dynamics within the industry are shifting, with New Oxygen gaining leverage to negotiate prices due to its expanding network of stores [7] - The rapid development of the medical beauty industry has led to improved policy approval efficiency, resulting in a significant increase in the number of approved products [9] Group 2: Pricing Strategies - New Oxygen's founder, Jin Xing, aims to lower the prices of medical beauty projects, challenging the traditional high-price system that has persisted in the industry [3] - The introduction of New Oxygen's "Miracle Youth Needle" project at a price of 4,999 yuan per unit significantly undercuts the established market price, leading to backlash from suppliers [4] - The company has continued to innovate with pricing strategies, launching further iterations of its youth needle products at even lower prices, such as 2,999 yuan and 999 yuan [4] Group 3: Supplier Relationships - Despite previous conflicts, some brands that had publicly opposed New Oxygen have recently reconciled and entered into partnerships, indicating a shift in industry relationships [5] - New Oxygen's purchasing volume has reached significant levels, with some suppliers relying on the company for a substantial portion of their sales, fostering stable partnerships [9] Group 4: Future Outlook - The medical beauty industry is moving towards a model that emphasizes value over price competition, as the previous pricing wars have disrupted the long-standing pricing power of upstream manufacturers [10] - New Oxygen plans to expand its store presence significantly in key cities, aiming for a total of at least 35 new stores in 2026 [8] - The company remains optimistic about the future, believing that increased supply and improved technology will lead to more affordable services for consumers [8]

Core Viewpoint - The collaboration between medical beauty brands and "villains" signifies a shift in brand communication, aiming to inject confidence and vitality into the traditionally anxiety-ridden medical beauty marketing landscape [4][6]. Group 1: Industry Overview - The medical beauty industry in China has been characterized by a scarcity of quality and affordable services, leading to information asymmetry and regulatory gray areas that complicate consumer decision-making [9][10]. - Traditional medical beauty institutions often struggle with scalability, as many have been operating for over twenty years with limited store counts, typically between 20 to 40 [6][10]. - The industry is transitioning from a seller's market to a buyer's market due to an increase in product approvals, which is expected to enhance competition and reduce product scarcity [11][12]. Group 2: Company Development - New Oxygen has opened 50 direct-operated clinics across 16 cities and completed over 1 million treatments, positioning itself as a leader in the light medical beauty chain brand sector in China [5][4]. - The company has established the "Youth Selection Alliance," which sets stringent standards for product quality and aims to redefine what constitutes a "good product" in the market [15][16]. - New Oxygen's approach includes a focus on building a scalable and high-quality delivery system to address the industry's challenges of trust and efficiency [7][12]. Group 3: Supply Chain and Market Dynamics - The "Youth Selection Alliance" allows New Oxygen to leverage its treatment volume to negotiate better terms with suppliers, ensuring high-quality products are available to consumers [16][18]. - The company has formed partnerships with major pharmaceutical and medical beauty suppliers, significantly increasing its purchasing power and market influence [17][18]. - New Oxygen's strategy emphasizes the importance of a robust supply chain and efficient distribution channels, which are critical for driving down costs and enhancing product availability [20][21]. Group 4: Future Outlook - The transformation within the medical beauty industry is expected to lead to a healthier ecosystem and a more rational consumer market, characterized by increased choice, transparency, and trust [27][28]. - As the industry moves towards full market competition, companies that can effectively balance consumer trust and supply chain efficiency will thrive [27][28]. - New Oxygen's ongoing efforts to integrate technology and streamline operations are essential for overcoming existing industry challenges and achieving sustainable growth [22][28].